Shweta Walia, P. Varma
Abstract
Abnormal ocular neovascularization is major cause of loss of vision.The newly formed vessels are dysfunctional which can leak fluid, cause hemorrhage, or are associated with fibrous proliferation, resulting in potentially catastrophic loss of vision. Anti VEGF have come as a boon to cure ocular neovascularization. This paper will describe the attempted uses of bevacizumab , humanized monoclonal antibody to VEGF, for various ocular disorders and its efficacy in addition to discussing safety. Comments regarding appropriate use of this treatment are based on our current level of knowledge and large ,randomized control studies are required to expand the use of this wonderful drug.
Keywords
neovascularization; VEGF; anti VEGF; bevacuzimab
DOI: http://dx.doi.org/10.7439/ijpr.v3i4.55
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2014 International Journal of Pharmacological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.